Skip to content

A clinical study of a remote lifestyle support program for cancer patients receiving systemic chemotherapy

A clinical study of a remote lifestyle support program for cancer patients receiving systemic chemotherapy - A clinical study of a remote lifestyle support program for cancer patients receiving systemic chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052615
Enrollment
20
Registered
2023-10-26
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric or colorectal cancer

Interventions

Lifestyle support program under online

Sponsors

Aichi Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The study is fully explained and written consent is obtained from the patient. 2) Patients must be at least 18 years of age at the time of enrollment. 3) Patients must have primary cancer of the stomach or colon (including post-resection) 4) Patients are scheduled to receive at least 3 months of outpatient pharmacotherapy with a regimen including SOX/DS/CAPOX 5) Able to take oral intake.

Exclusion criteria

Exclusion criteria: 1) Musculoskeletal, cardiovascular, or cerebral nervous system disease requiring exercise restriction 2) Patient has a metabolic/endocrine, cardiovascular, or hepatic/renal disease requiring special nutritional guidance. 3) Other conditions that the physician deems inappropriate.

Design outcomes

Primary

MeasureTime frame
Completion rate of online lifestyle support Mobile app usage (frequency of use, time spent in app)

Secondary

MeasureTime frame
Percentage of questionnaire responses Lifestyle changes (physical activity, diet, diet-related quality of life, and changes in fatigue scores)

Countries

Japan

Contacts

Public ContactHiroya Taniguchi

Aichi Cancer Center Hospital Department of Clinical Oncology

hiroya.taniguchi@aichi-cc.jp0527626111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026